Literature DB >> 6108540

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.

M N Rossor, P C Emson, C Q Mountjoy, M Roth, L L Iversen.   

Abstract

Post-mortem brain tissue from 15 patients dying with a diagnosis of senile dementia of Alzheimer type (SDAT) was compared with tissue obtained from 16 control patients at routine post-mortem. A significant fall in choline acetyltransferase (ChAT) activity was observed in the cortex, hippocampus and amygdala of the SDAT cases and was maximal in the temporal cortex. The fall in ChAT activity observed in the temporal cortex was accompanied by a significant reduction (47%) in immunoreactive somatostatin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108540     DOI: 10.1016/0304-3940(80)90177-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

1.  NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.

Authors:  J W Unger; W Lange
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Further studies of the effects of somatostatin and related peptides in area CA1 of rabbit hippocampus.

Authors:  H E Scharfman; P A Schwartzkroin
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

3.  Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Authors:  F P Zemlan
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

5.  Somatostatin-like immunoreactivity in non-pyramidal neurons of the human isocortex.

Authors:  E Braak; H Braak; A Weindl
Journal:  Anat Embryol (Berl)       Date:  1985

6.  Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

Authors:  K Fujiyoshi; H Suga; K Okamoto; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

7.  Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

Authors:  M N Rossor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

8.  Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.

Authors:  S J Kish; Y Robitaille; M el-Awar; L Schut; L DiStefano; M J Ball; M F Mazurek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

9.  Neurochemical characteristics of early and late onset types of Alzheimer's disease.

Authors:  M N Rossor; L L Iversen; G P Reynolds; C Q Mountjoy; M Roth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

10.  Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures.

Authors:  J Y Koh; E Palmer; C W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.